A vaccine for human babesiosis: prospects and feasibility

被引:5
|
作者
Al-Nazal, Hanan [1 ]
Low, Leanne M. [2 ]
Kumar, Sanjai [3 ]
Good, Michael F. [1 ]
Stanisic, Danielle I. [1 ]
机构
[1] Griffith Univ, Inst Glyc, Gold Coast Campus, Griffith, Qld, Australia
[2] Natl Inst Allergy & Infect Dis, NIH, Lab Malaria & Vector Res, Rockville, MD USA
[3] FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Res & Review, Silver Spring, MD USA
基金
英国医学研究理事会;
关键词
RHOPTRY NECK PROTEIN-2; MICROTI INFECTION; BOVINE BABESIOSIS; GAMMA-INTERFERON; PROTECTIVE IMMUNITY; MALARIA PARASITE; T-CELLS; ANTIGENS; CATTLE; CANIS;
D O I
10.1016/j.pt.2022.07.005
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Babesiosis is a tick-borne disease caused by intraerythrocytic Babesia parasites. It is a well-known illness in companion animals and livestock, resulting in substan-tial economic losses in the cattle industry. Babesiosis is also recognized as an emerging zoonosis of humans in many countries worldwide. There is no vaccine against human babesiosis. Currently, preventive measures are focused on vector avoidance. Although not always effective, treatment includes antimicrobial therapy and exchange transfusion. In this review, we discuss the host's immune response to the parasite, vaccines being used to prevent babesiosis in animals, and lessons from malaria vaccine development efforts to inform the development of a human babesiosis vaccine. An effective human vaccine would be a significant advance towards curtailing this rapidly emerging disease.
引用
收藏
页码:904 / 918
页数:15
相关论文
共 50 条
  • [31] VACCINE PROSPECTS FOR HUMAN PARASITES OTHER THAN MALARIA
    JAMES, SL
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) : 1354 - 1355
  • [33] PROSPECTS FOR A HUMAN B19 PARVOVIRUS VACCINE
    COLLET, MS
    YOUNG, NS
    REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (02) : 91 - 103
  • [34] EPIZOOTIOLOGY OF HUMAN BABESIOSIS
    SPIELMAN, A
    PIESMAN, J
    ETKIND, P
    JOURNAL OF THE NEW YORK ENTOMOLOGICAL SOCIETY, 1977, 85 (04): : 214 - 216
  • [35] Characteristics of Human Babesiosis in Europe
    Hildebrandt, Anke
    Gray, Jeremy
    Montero, Estrella
    PATHOGENS, 2023, 12 (02):
  • [36] Human babesiosis or pseudo malaria
    Marsaudon, E
    Barrault, MF
    Testou, D
    Cahiez, M
    MEDECINE ET MALADIES INFECTIEUSES, 1997, 27 (02): : 84 - 87
  • [38] Prospects for human papillomavirus vaccine development: Emerging HPV vaccines
    Hines, JF
    Ghim, S
    Jenson, AB
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1998, 10 (01) : 15 - 19
  • [39] Prospects for human papillomavirus vaccine development: emerging HPV vaccines
    Hines, JF
    Ghim, SJ
    Jenson, AB
    CURRENT OPINION IN INFECTIOUS DISEASES, 1998, 11 (01) : 57 - 61
  • [40] Attenuated trivalent vaccine against babesiosis and anaplasmosis in Colombia
    Benavides, E
    Vizcaino, O
    Britto, CM
    Romero, A
    Rubio, A
    TROPICAL VETERINARY DISEASES: CONTROL AND PREVENTION IN THE CONTEXT OF THE NEW WORLD ORDER, 2000, 916 : 613 - 616